donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
DOCS Doximity
41.500
+2.550+6.55%
Post Mkt Price
41.50000.00%
YOY
Do not show
Hide blank lines
(FY)2022/03/31(Q4)2022/03/31(Q3)2021/12/31(Q2)2021/09/30
Investing cash flow
Cash flow from continuing investing activities
-809.69% -640.57M 44.89% -23.63M 6.41% -25.52M -3775.44% -534.01M
Capital expenditure reported
-- -- -- -- 0.37% -1.07M 34.74% -900K
Net PPE purchase and sale
-680.41% -1.91M -621.09% -1.06M -10083.33% -611K -198.51% -200K
Net intangibles purchase and sale
-- -3.79M -- -1.05M -- -- -- --
Net business purchase and sale
-- 0 -- 0 -- 0 -- 0
Net investment purchase and sale
-1557.34% -635.47M 47.28% -22.11M 21.56% -23.84M -3430.66% -532.91M
Net other investing changes
5058.33% 595K -- 595K -- -- -- --
Cash from discontinued investing activities
Investing cash flow
-809.69% -640.57M 44.89% -23.63M 6.41% -25.52M -3775.44% -534.01M
Financing cash flow
Cash flow from continuing financing activities
10264.62% 560.42M 153% 4.39M 63.25% 3.79M -95.28% 53K
Net common stock issuance
27360.48% 551.21M -- 0 -- 0 -- 0
Proceeds from stock option exercised by employees
57.44% 14.01M 6.66% 4.77M 35.74% 4.17M 106.67% 2.32M
Net other financing activities
-226.91% -4.8M 64.95% -381K -- -380K -- -2.27M
Cash from discontinued financing activities
Financing cash flow
10264.62% 560.42M 153% 4.39M 63.25% 3.79M -95.28% 53K
Net cash flow
Beginning cash position
37.09% 66.39M 21.58% 85.08M 12.07% 79.52M 1295.02% 594.32M
Current changes in cash
158.4% 46.42M 874.15% 27.73M 665.99% 5.56M -1915.62% -514.8M
End cash Position
69.91% 112.81M 69.91% 112.81M 21.58% 85.08M 12.07% 79.52M
Free cash flow
54.25% 120.88M 22.43% 44.86M 11.89% 25.61M 60.39% 18.05M
Investing cash flow
Cash flow from continuing investing activities
-809.69% -640.57M 44.89% -23.63M 6.41% -25.52M -3775.44% -534.01M
Capital expenditure reported
-- -- -- -- 0.37% -1.07M 34.74% -900K
Net PPE purchase and sale
-680.41% -1.91M -621.09% -1.06M -10083.33% -611K -198.51% -200K
Net intangibles purchase and sale
-- -3.79M -- -1.05M -- -- -- --
Net business purchase and sale
-- 0 -- 0 -- 0 -- 0
Net investment purchase and sale
-1557.34% -635.47M 47.28% -22.11M 21.56% -23.84M -3430.66% -532.91M
Net other investing changes
5058.33% 595K -- 595K -- -- -- --
Cash from discontinued investing activities
Investing cash flow
-809.69% -640.57M 44.89% -23.63M 6.41% -25.52M -3775.44% -534.01M
Financing cash flow
Cash flow from continuing financing activities
10264.62% 560.42M 153% 4.39M 63.25% 3.79M -95.28% 53K
Net common stock issuance
27360.48% 551.21M -- 0 -- 0 -- 0
Proceeds from stock option exercised by employees
57.44% 14.01M 6.66% 4.77M 35.74% 4.17M 106.67% 2.32M
Net other financing activities
-226.91% -4.8M 64.95% -381K -- -380K -- -2.27M
Cash from discontinued financing activities
Financing cash flow
10264.62% 560.42M 153% 4.39M 63.25% 3.79M -95.28% 53K
Net cash flow
Beginning cash position
37.09% 66.39M 21.58% 85.08M 12.07% 79.52M 1295.02% 594.32M
Current changes in cash
158.4% 46.42M 874.15% 27.73M 665.99% 5.56M -1915.62% -514.8M
End cash Position
69.91% 112.81M 69.91% 112.81M 21.58% 85.08M 12.07% 79.52M
Free cash flow
54.25% 120.88M 22.43% 44.86M 11.89% 25.61M 60.39% 18.05M
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
Unqualified Opinion------

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
CEO: Tangney, Jeffrey A.
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...